LENMELDY
Live / Registered — Registered (as of 02 Jun 2026)
What this means for you
Registered since 02 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2032: the §8 declaration of use).
Record
- Serial number
- 98028058
- Registration number
- 8285631
- Mark type
- Word mark
- Filed
- 05 Jun 2023
- Published for opposition
- 02 Apr 2024
- Registered
- 02 Jun 2026
- Next maintenance filing
- §8 declaration of use, due by 02 Jun 2032 (grace period to 02 Dec 2032)
- Attorney of record
- Michael J. Belliveau
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of orphan diseases, namely, inherited neuro-degenerative disorders; Medicinal preparations for the treatment of orphan diseases, namely, inherited neuro-degenerative disorders
Owner
- KYOWA KIRIN CO., LTD., TOKYO, JP
- Orchard Therapeutics (Europe) Limited, London, GB
- Orchard Therapeutics (Europe) Limited, London, GB
- Orchard Therapeutics (Europe) Limited, London, GB
Prosecution history
- 07 Oct 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 12 May 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 May 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Dec 2025 — USE AMENDMENT FILED
- 06 May 2026 — SOU EXTENSION 3 GRANTED
- 02 Dec 2025 — SOU EXTENSION 3 FILED
- 06 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2025 — SOU EXTENSION 2 GRANTED